Vancouver, British Columbia, November 04, 2024 – TheNewswire - Anonymous Intelligence Company Inc. (CSE: ANON) (OTC: ANICF) (FRANKFURT: 1JI0) (“ANON” or the “Company”), a leading decentralized network, data storage technology and AI tools developer company, is pleased to announce a strategic alliance with CannÖgen International Inc. (CannÖgen), a health and wellness, nutrient formulation company based in Vancouver, BC, whereby ANON will provide the technology products and services needed by CannÖgen to support their global sales and marketing initiatives (the “Transaction”).  

 

In ANON’s last press release sent out on Monday, October 28, 2024, the Company announced that it was in discussions with a health and wellness company, CannÖgen International Inc, to provide them with technology and services to support their global growth.  Today, we are announcing that we have completed the discussions and have inked the deal to start our strategic relationship.

 

ANON’s CEO, Denis Franks, states, “I see tremendous opportunity in working with CannÖgen, as their science-based nutrient formulations for brain, bone, weight management and medical food supplements are the type of initiatives that positively impact society, along with building ANON shareholder value.  We look forward to being part of their continued success. Medical science meets technology, a great combination!”

 

CannÖgen’s CEO, Allan Larmour, states, “ CannÖgen is a science-based Health & Wellness company that has unique, patented Health Composition Products, Medical Foods, pHuel Beverage Products and Pet Products that target health issues with optimal potency. ANON has the products and services that can provide the high level of professionalism, integrity, and depth of marketing exposure globally that coincides with the integrity and expertise that Dr. Larry McCleary and his safe, all-natural health and wellness products bring to the nutraceutical market space. We look forward to working with ANON and building a strong, mutually beneficial partnership.”  

 

ANON’s technology and services that include SEO, website expertise and development, AI tools and development, and extensive market reach with their global contacts and social media networking will provide the necessary foundation for CannÖgen’s strategic sales, marketing and analytical initiatives that will drive global sales.  CannÖgen has perpetual, world-wide, and exclusive rights to market and sell Dr. Larry McCleary’s health and wellness products.  Dr. Larry McCleary, a pediatric neurosurgeon based in the U.S., spent over 10 years of research on how to use all natural nutrients to help his young patients heal more quickly after brain surgery. He developed 3 science-based, safe and all natural nutrient formulations that achieved that goal. Dr. McCleary decided to bring these products to market and achieved over US$70M in revenue in the U.S.  The 3 products are, Lucidal for brain health, Vitaloss for weight loss and management, and Bonexid for bone health – all supported by gold standard clinical trials.  Dr. McCleary has over 20 more products ready to go that include medical foods that help with specific medical issues, pet health formulations and health beverages. CannÖgen has re-introduced the 3 products shown above and initially has brought out 2 new products, Serenotene for helping people sleep and Promenstra to manage PMS issues for women, using all natural and safe ingredients.  The more than 20 new products will be introduced slowly on a quarterly basis.

 

As part of the strategic agreement between ANON and CannÖgen and in consideration for ANON’s services, CannÖgen will issue to ANON 444,444 warrants exercisable to acquire one common share of CannÖgen at a price of $0.1125 per share for a period of two years. The Transaction is a non-arm’s length transaction as Allan Larmour, a director of the Company, also serves as CEO and a director of CannÖgen.

 

The Transaction is subject to the approval of the Canadian Securities Exchange.

 

On Behalf of the Board,

ANONYMOUS INTELLIGENCE COMPANY INC.

 

Denis Franks

CEO

 

About Anonymous Intelligence Company Inc.

 

Anonymous Intelligence Company Inc. (CSE: ANON) (OTC: ANICF) (FRANKFURT: 1JI0) is a leading computational intelligence, decentralized network, and data technology company. Leveraging its proprietary suite of AI and privacy-enabled products, ANON aims to empower individuals and businesses to have increased confidence in technology. Through its innovative solutions, ANON is committed to delivering cutting-edge technology while prioritizing user privacy and data security. For more information about Anonymous Intelligence Company and its suite of products, please visit www.anonintelligence.com  

 

Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy of accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein

 

Forward-Looking Statements

 

Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding: the potential for the Company’s products and services; the Company’s ability to add additional features to the Company’s products and services; and the Company’s ability to work with CannÖgen and deliver the products and services it needs for its business operations.

Factors that could cause actual results to differ materially from those in forward-looking statements include: the continued availability of capital and financing; the impact of technology changes on the industry; lack of demand for the Company’s products and services; competition; increase in operating costs; loss of key employees, consultants and directors; security threats; failure to develop new and innovative products and services; failure of counterparties to perform their obligations; and adverse general economic, market or business conditions. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the demand for its products and services, the ability to successfully develop software, that there will be no regulation or law that will prevent the Company from operating its business, anticipated costs, and the ability to secure sufficient capital to complete its business plans. Given these risks, uncertainties, and assumptions, you should not place undue reliance on these forward-looking statements. Such forward-looking statements should therefore be construed in light of such factors, and, except as required by applicable law, the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.